Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.91
-1.48 (-5.04%)
At close: Apr 28, 2026, 4:00 PM EDT
28.00
+0.09 (0.32%)
Pre-market: Apr 29, 2026, 4:25 AM EDT

Company Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.

The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.

Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.

Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.

The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.
Hims & Hers Health logo
Country United States
Founded 2017
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,442
CEO Andrew Dudum

Contact Details

Address:
2269 Chestnut Street, Suite 523
San Francisco, California 94123
United States
Phone 415 851 0195
Website hims.com

Stock Details

Ticker Symbol HIMS
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001773751
CUSIP Number 433000106
ISIN Number US4330001060
SIC Code 8011

Key Executives

Name Position
Andrew Dudum Co-Founder, Chairman and Chief Executive Officer
Oluyemi Okupe Chief Financial Officer
Mike Chi Chief Operating Officer
Soleil Teubner Boughton J.D. Chief Legal Officer and Corporate Secretary
Dr. Patrick Carroll M.D. Chief Medical Officer and Director
Deborah M. Autor J.D. Chief Policy Officer and Director
Irene A. Becklund Senior Vice President, Controller and Principal Accounting Officer
Mohamed ElShenawy Chief Technology Officer
Kathryn H. Beiser B.A., M.S. Chief Communications Officer
Dr. Peter Stahl M.D. Senior Vice President of Men's Reproductive and Sexual Health

Latest SEC Filings

Date Type Title
Apr 28, 2026 ARS Filing
Apr 28, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2026 DEF 14A Other definitive proxy statements
Apr 20, 2026 144 Filing
Apr 6, 2026 144 Filing
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 17, 2026 144 Filing
Mar 17, 2026 144 Filing
Mar 17, 2026 144 Filing
Mar 11, 2026 8-K Current Report